Short description
OncoSenX is a developer of transient gene therapies designed for solid tumors.
Description
OncoSenX is a developer of transient gene therapies designed for solid tumors. The company's therapy delivers plasmid DNA with a novel lipid nanoparticle that selectively kills cancerous cells based on their transcriptional activity, providing cancer patients, doctors and medical care professionals with a less invasive and more precise intervention for this complex and devastating disease.
Last funding
Noaccess
Sign in for full access
Total funding
$$121212
Sign in for full access
Location
Seattle, Washington, United States, North America
Founded on
January 1, 2017
Non-profit?
No
Acquired?
No
Employees count
1-10
Revenue range
$1230 - 4560
Sign in for full access
Investors
Noaccess, Absolutely Noaccess, Absolutely Noaccess, Uh Ohhhh, Nopepepe, No Way, Cannot Access, Cannot Access
Sign in for full access
Founders
John Lewis, Matthew Scholz